BDXB

Becton Dickinson And Co

• Reuters·9h ago

  US FDA approves Waters' at‑home cervical cancer screening kit

• Reuters·12h ago

  BD wins EU CE mark for Liverty TIPS stent graft in portal hypertension care

• Reuters·04/01 09:01

  BD launches Pyxis Pro AI-enabled medication dispensing system in Europe

• Reuters·03/17 18:44

  BD EVP and General Counsel Lanesha Minnix files initial beneficial ownership statement

• Reuters·03/12 20:17

  KORU Medical names Adam Kalbermatten CEO as Linda Tharby retires June 30, 2026

• Reuters·03/11 10:06

  BD and Sinteco sign technology partnership for connected medication management in Europe

• Reuters·03/10 12:41

  BECTON DICKINSON EXEC SAYS MIDDLE EAST EXPOSURE IS WITHIN 2% RANGE, ADDS REGION HAS BEEN A STRONG CONTRIBUTOR- BARCLAYS CONF

• Reuters·03/10 12:41

  BECTON DICKINSON EXEC SAYS COMPANY WILL CONTINUE PURSUING TUCK‑IN M&A IN HIGH‑GROWTH AREAS – BARCLAYS CONF

• Reuters·03/05 07:13

  BD wins CE mark for Revello vascular covered stent in EU

• Reuters·03/05 07:10

  BRIEF-BD Advances Iliac Artery Treatment Across The European Union

• Reuters·03/02 11:50

  FDA grants BD 510(k) clearance for Surgiphor 1000mL antimicrobial irrigation system

• Reuters·02/27 22:46

  BD EVP and Chief Revenue Officer Michael Feld Disposes of Becton, Dickinson and Company Common Shares

• Reuters·02/25 21:27

  BD Prices $2 Billion Debt Tender Offers, Accepts Notes for Purchase

• Reuters·02/25 21:15

  BD: PURCHASE FOR CASH UP TO $2 BLN AGGREGATE PURCHASE PRICE, EXCLUDING APPLICABLE ACCRUED INTEREST

• Reuters·02/25 13:08

  BD: EXERCISED RIGHT TO AMEND CERTAIN TENDER OFFERS; INCREASES AGGREGATE OFFER CAP TO $2 BLN